Nature Communications (Aug 2022)

Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo

  • Huanzhen Ni,
  • Marine Z. C. Hatit,
  • Kun Zhao,
  • David Loughrey,
  • Melissa P. Lokugamage,
  • Hannah E. Peck,
  • Ada Del Cid,
  • Abinaya Muralidharan,
  • YongTae Kim,
  • Philip J. Santangelo,
  • James E. Dahlman

DOI
https://doi.org/10.1038/s41467-022-32281-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 9

Abstract

Read online

Next-generation lipid nanoparticles that target non-hepatocytes could be important clinical tools. Using in vivo DNA barcoding, the authors identify piperazine-containing lipids deliver mRNA to immune cells without targeting ligands.